Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-06

FDA Approved: ROFLUMILAST — Supplemental Application (Solco Healthcare US, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for a generic roflumilast product from Solco Healthcare US, LLC. This approval makes a generic COPD therapy more wid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

SUPPL AP for ROFLUMILAST (ROFLUMILAST)